BioStock: BiBBInstruments completes bladder cancer study

Medtech company BiBBInstruments is tackling one of the major challenges within cancer diagnostics – catching muscle invasive bladder cancer at its early stages without the need for an invasive procedure called Transurethral Resection for Bladder Tumour, or TURBT. The company’s motorised biopsy device EndoDrill URO is being developed with that goal in mind, and BiBBInstruments has announced that its pilot study with the device has been completed.

Read the article at biostock.se:

https://www.biostock.se/en/bibbinstruments-completes-bladder-cancer-study

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/